yeah the only way out of this mess is for cxbladder to be included in AUA Microhematuria guidelines. Novitas refers to bladder cancer: non invasive guidelines from AUA, however, cxbladder is more or less about ruling out negatives in low-risk patients with microhematuria.
I doubt microhematuria guidelines will come out in time to support PEB though. I see this stock dropping to 5c 6c on Monday unfortunately
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.25M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1445 | 8.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.9¢ | 15969 | 1 |
View Market Depth
| Last trade - 10.06am 16/06/2025 (20 minute delay) ? |
| PEB (ASX) Chart |
Day chart unavailable